SCHEMBL31689650

SCHEMBL31689650

CC(C)(C)OC(=O)NC(=N)c1ccc2cc(C(=O)O)[nH]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF4A3 P38919 2/20 0.47
▸ PLG P00747 1/20 0.43
▸ PLAU P00749 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ DAO P14920 1/20 0.40
▸ SRD5A2 P31213 1/20 0.40
▸ ALOX15 P16050 2/20 0.38
▸ ITGB3 P05106 1/20 0.38
▸ ITGA2B P08514 1/20 0.38
▸ PIN1 Q13526 1/20 0.38
▸ GPR35 Q9HC97 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ SMAD3 P84022 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21822456 1.00 EIF4A3 (0.47) EIF4A3PLGPLAUKDM4EHSD17B10
SCHEMBL21822374 0.85 ALOX15 (0.53) PLGPLAUKDM4EHSD17B10MAPT
SCHEMBL25016345 0.82 RET (0.41) ALOX15ITGB3ITGA2B
SCHEMBL3035898 0.78 LEF1 (0.49) EIF4A3KDM4EHSD17B10MAPTHPGD
SCHEMBL617014 0.76 MAPT (0.52) MAPTSRD5A2ALDH1A1GABRB1GABRB2
SCHEMBL21822433 0.76 KDM4E (0.53) PLGKDM4E
SCHEMBL6947975 0.76 HRH3 (0.52) EIF4A3PLGPLAUKDM4EHSD17B10
SCHEMBL16808294 0.75 NQO2 (0.45) PLAUKDM4EHSD17B10MAPTHPGD
SCHEMBL28415588 0.74 EIF4A3 (0.55) EIF4A3PLGPLAUKDM4EHSD17B10
SCHEMBL30445643 0.73 HSD17B10 (0.61) EIF4A3PLGPLAUKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428415-B2 Matriptase 2 inhibitors and uses thereof DISC MEDICINE, INC. (US) 2025-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428415-B2 Matriptase 2 inhibitors and uses thereof MMP7, MATR3, SPINT2 EIF4A3 2857/4885PLG 225/4885PLAU 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback